semaglutide diverticulitis and Diverticulitis: Safety Considerations Ozempic and Diverticulitis: Exploring the

GLP-1 receptor agonists tend to have a stronger effect on appetite and body weight than metformin

Ikeda T, et al

Food and Drug Administration by the end of the second quarter INDIANAPOLIS, June 8, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from three Phase 3 trials in the ACHIEVE program evaluating Foundayo (orforglipron), a small molecule oral GLP-1 taken without food or water restrictions, in adults with type 2 diabetes

Treatment Recommendations for Histamine Intolerance While lifestyle modifications can help alleviate symptoms, treatment may be necessary for severe cases of histamine intolerance

The third generation, built around a single drug called retatrutide, works on three receptors and has just produced 28.7% weight loss in a Phase 3 trial, which is the range that bariatric surgery produces